Clinical Trials Directory

Trials / Completed

CompletedNCT04964739

Gender/Sex & CUD Remission

Gender and Sex Hormone Influences on Cannabis Use Disorder Remission

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
224 (actual)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Adults (ages 18+) who would like to reduce their cannabis use (N=224) will be enrolled in an 8-week treatment program. All participants will receive counseling (1 goals session with a therapist followed by 7 weekly computerized cognitive-behavioral therapy sessions). Detailed cannabis assessments (biological and self-report) will be conducted throughout treatment and at 1-, 2-, and 3-months post-treatment completion. Daily electronic diaries will be administered via text message to record detailed logs of cannabis use quantity and frequency. Salivary samples will be collected (and video observed) daily throughout treatment to analyze for progesterone.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive Behavioral Therapy (CBT4CBT)Participants will receive one therapist-led motivational interviewing/goal setting session followed by 7 sessions of computerized CBT4CBT.

Timeline

Start date
2021-11-15
Primary completion
2025-10-27
Completion
2025-10-27
First posted
2021-07-16
Last updated
2025-11-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04964739. Inclusion in this directory is not an endorsement.

Gender/Sex & CUD Remission (NCT04964739) · Clinical Trials Directory